Biomec Inc.

Putting the research of universities and other institutions to commercial use, particularly in the field of medical devices, remains Biomec's primary focus.

Trevor O. Jones, a veteran engineer who designed General Motors Corp.'s first electronic crash sensor for air bags and started up TRW Inc.'s automotive electronics group, was set to retire last spring. Then came an April 1998 meeting of the Cleveland Clinic Foundation 's scientific advisory council at which Jones heard council members discuss the need to develop a better means for commercializing the foundation's considerable body of research. Jones, who had previously launched several ventures for TRW and GM, saw the opportunity to set up a business that would mine the rich—and largely untapped—body of innovative research coming out of major medical institutions like the Cleveland Clinic, with an eye towards developing products with market potential. Putting aside his dreams of a life of leisure for another day, Jones joined with J. Frederick Cornhill, chairman of the clinic's biomedical engineering department to found Biomec Inc.

Biomec's business plan has gone considerably beyond turning some of the clinic's research into profits and devices for medical use....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

PathAI Talks PCCPs: ‘Accelerated Software Updates, Saves Time And Money’

 

The US FDA has authorized around 107 devices with Predetermined Change Control Plans in place, with PathAI's AISight Dx digital pathology image management system one of the latest. Medtech Insight talks to Eric Walk, chief medical officer, to find out about the process and its benefits.

Ultromics Wins $55M, The Key To Success: Diagnosing Diseases With Available Treatment

 

Ultromics has secured $55m in Series C funding to advance its AI tool, EchoGo, which detects undiagnosed heart failure. The company's focus on diseases with available treatments resonated with investors.

Stryker Revises FY25 Tariff Estimate To $175M From $200M As EU Trade Pressures Mount

 
• By 

Kevin Lobo, chairman and CEO of Stryker said that the company is not as exposed to China as others and has manufacturing operations in Europe, influencing the overall tariff impact.

Siemens Healthineers Mitigates Headwinds With ‘Value-Add Structural Changes’

 

Siemens Healthineers anticipates €400m-€500m tariff impact by 2026 but says it will mitigate losses through structural changes and pricing. Despite a revenue decline in diagnostics due to China’s VBP, diagnostics transformation activities, including cutting product, were “successful."

More from Business

Additional Death And Injuries Added To 2024 Philips Ventilator Recall

 

Philips Respironics has updated instructions for use for three ventilators that were included in a May 2024 recall. The company also added three potential injuries and one death to the original number.

Ultromics Wins $55M, The Key To Success: Diagnosing Diseases With Available Treatment

 

Ultromics has secured $55m in Series C funding to advance its AI tool, EchoGo, which detects undiagnosed heart failure. The company's focus on diseases with available treatments resonated with investors.

Stryker Revises FY25 Tariff Estimate To $175M From $200M As EU Trade Pressures Mount

 
• By 

Kevin Lobo, chairman and CEO of Stryker said that the company is not as exposed to China as others and has manufacturing operations in Europe, influencing the overall tariff impact.